ACCOUNTS RECEIVABLE |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ACCOUNTS RECEIVABLE | ACCOUNTS RECEIVABLE The following table sets forth the details of the Company’s accounts receivable, net balances included on the condensed consolidated balance sheets as of June 30, 2025 and December 31, 2024:
As of January 1, 2024, the Company’s accounts receivable balance was $52.4 million.
Bad debt expense was $0.2 million for the three months ended June 30, 2025 and 2024, and $0.4 million for the six months ended June 30, 2025 and 2024, respectively. Write-offs were $0.2 million and immaterial for the three months ended June 30, 2025 and 2024, respectively, and $0.5 million and immaterial for the six months ended June 30, 2025 and 2024, respectively. Recoveries were immaterial for the three months ended June 30, 2025 and 2024, respectively, and $0.1 million and immaterial for the six months ended June 30, 2025 and 2024, respectively.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- Definition The entire disclosure for claims held for amounts due to entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- References No definition available.
|